对比增强磁共振成像后骨组织中的钆沉积:综合综述
本综述聚焦钆离子(Gd3+)在骨组织中的归转,指出Gd3+可在骨中长期存留,线性配体结构的钆基对比剂较大环类对比剂滞留更高;滞留的Gd很大比例并非原始完整钆基对比剂形式,虽迄今未有对骨生理的直接临床后果报道,但提出潜在毒理学担忧,并讨论Gd3+与羟基磷灰石、胶原及蛋白聚糖的相互作用及对骨重塑和细胞功能的可能干扰。
要点
- 线性配体钆基对比剂在骨中的钆滞留高于大环类对比剂。
- 骨中滞留的钆很大比例并非原始完整注射的钆基对比剂形式。
- 迄今尚无对骨生理产生直接临床后果的报道。
核心结论
- Gd3+可在骨组织中长期存留,线性配体结构钆基对比剂的骨滞留高于大环类对比剂。
- 滞留的钆很大比例以非原始完整注射钆基对比剂形式存在,引发潜在毒理学担忧,但迄今尚无对骨生理的直接临床后果报道。
- Gd3+与骨基质成分(羟基磷灰石、胶原、蛋白聚糖)的复杂相互作用可能参与钆滞留机制。
- 体外研究提示Gd可能干扰骨重塑过程和细胞功能,并与其他稀土元素的已知作用相比较。
研究设计与样本
- 综述类文章,检索范围与纳入文献原文未报告。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Over the past 15 years, significant advancements have been made in understanding the pharmacology and toxicology of gadolinium-based contrast agents (GBCAs), widely used in magnetic resonance imaging (MRI). This review focuses on the fate of gadolinium cation (Gd 3+ ) in bone tissues. The evidence indicates that Gd 3+ can persist in bone for extended periods, with higher retention observed for GBCAs with linear ligand structures as opposed to macrocyclic ones. The prolonged presence of Gd, with a significant proportion in species other than the initial intact injected GBCA form, raises concerns about potential toxicological effects, although no direct clinical consequences on bone physiology have been reported so far. This review discusses the complex interactions between Gd 3+ and bone matrix components, such as hydroxyapatite, collagen, and proteoglycans, which might contribute to the mechanisms of Gd retention. It also explores the potential for Gd to interfere with bone remodelling processes and cellular functions, as suggested by in vitro studies, and in comparison with that known for other rare earth elements (REE).
引用
- Fretellier N, Idée JM, Rasschaert M, et al. Gadolinium Deposition in Bone Tissues After Contrast-enhanced Magnetic Resonance Imaging: A Comprehensive Review. Invest Radiol. 2025. PMID: 40574249. doi:10.1097/RLI.0000000000001208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。